Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?

被引:0
|
作者
Goupille, Philippe [1 ]
Wendling, Daniel [2 ]
机构
[1] Univ Tours, Trousseau Hosp, Rheumatol Dept, CHU Tours,EA 6295, Ave Republ, F-37044 Tours 9, France
[2] Univ Franche Comte, Rheumatol Dept, CHU Besancon, EA 4266, Besancon, France
关键词
Axial spondyloarthritis; Treatment; C-reactive protein; CLINICAL-RESPONSE; DOUBLE-BLIND; ADALIMUMAB; PREDICTORS; EFFICACY; THERAPY; SAFETY;
D O I
10.1016/j.jbspin.2023.105662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 29 条
  • [21] Serum albumin and C-reactive protein week 2/week 0 ratio after anti-TNF therapy best predict both short- and long-term clinical outcomes in anti-TNF-naive ulcerative colitis patients
    Lee, S. -H.
    Chang, K.
    Song, E. M.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S273 - S274
  • [22] Erythrocyte Sedimentation Rate, C-Reactive Protein Level, and Serum Amyloid A Protein for Patient Selection and Monitoring of Anti-Tumor Necrosis Factor Treatment in Ankylosing Spondylitis
    de Vries, Mirjam K.
    van Eijk, Izhar C.
    van der Horst-Bruinsma, Irene E.
    Peters, Mike J. L.
    Nurmohamed, Michael T.
    Dijkmans, Ben A. C.
    Hazenberg, Bouke P. C.
    Wolbink, Gerrit J.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (11): : 1484 - 1490
  • [23] Response to Ixekizumab by C-reactive Protein Level in Patients with Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naive) and COAST-W (TNF Inhibitor-Experienced) Trials at 52 Weeks
    Reveille, John
    Rahman, Proton
    Sandoval, David
    Muran, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    Van den Bosch, Filip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Reduction of high-sensitivity C-reactive protein after treatment with anti-spastic agents in patients with coronary vasospastic angina and no hemodynamically significant coronary artery disease
    Hung, MJ
    CHEST, 2004, 126 (04) : 825S - 826S
  • [25] IXEKIZUMAB IS EFFECTIVE IN THE TREATMENT OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS REGARDLESS OF THE LEVEL OF C-REACTIVE PROTEIN OR MAGNETIC RESONANCE IMAGING SCORES: 16-WEEK DATA FROM COAST-V AND COAST-W
    Maksymowych, Walter P.
    Gallo, Gaia
    Bolce, Rebecca
    Zhao, Fangyi
    Geneus, Vladimir
    Ostergaard, Mikkel
    Tada, Kurisu
    Deodhar, Atul
    Gensler, Lianne S.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 884 - 885
  • [26] RESPONSE TO IXEKIZUMAB BY C-REACTIVE PROTEIN LEVEL IN PATIENTS WITH AADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE COAST-V (BIOLOGICAL-NAIVE) AND COAST-W (TNF-α INHIBITOR-EXPERIENCED) TRIALS AT 52 WEEKS
    Reveille, John D.
    Rahman, Proton
    Calderon, David M. Sandoval
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose A.
    van den Bosch, Filip
    RHEUMATOLOGY, 2021, 60
  • [27] RESPONSE TO IXEKIZUMAB BY C-REACTIVE PROTEIN LEVEL IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE COAST-V (BIOLOGICAL-NAIVE) AND COAST-W (TNF-A INHIBITOR-EXPERIENCED) TRIALS AT 52 WEEKS
    Chaudhury, Koyel
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    Robinson, Philip
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 34 - 35
  • [28] Response to Ixekizumab by C-reactive Protein Level in Patients With Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naive) and COAST-W (TNF- alpha Inhibitor-Experienced) Trials at 52 Weeks
    Reveille, John
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1121 - 1121
  • [29] P194 Response to ixekizumab by C-reactive protein level in patients with aadiographic axial spondyloarthritis: results from the COAST-V (biological-naive) and COAST-W (TNF-alpha inhibitor-experienced) trials at 52 weeks
    Reveille, John D.
    Rahman, Proton
    Calderon, David M. Sandoval
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose A.
    van den Bosch, Filip
    RHEUMATOLOGY, 2021, 60